Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

NINDS Neuroscience Funding Announcements



NINDS Direct Phase II SBIR Grants to Support Exploratory Clinical Trials (R44)

Funding Contact(s): Stephanie Fertig, MBA
Funding Categories: Small Business, Translational Research

Brief Description:

The purpose of this funding opportunity announcement (FOA) is to support Direct-to-Phase II exploratory clinical trials at the NINDS. For this FOA, the small business has demonstrated the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential. The goal of this FOA is to enable a small business that has accomplished the objectives of a Phase I SBIR grant through non-SBIR funds to initiate the Phase II SBIR stage of development, without needing to perform more early stage, Phase-I-SBIR-type research.



Grant Mechanism: R44
NIH Guide: PAR-14-265
Release Date: 2014-06-20
Expiration Date: 2017-01-08